Stay updated on MEK162 vs Dacarbazine in NRAS+ Melanoma Clinical Trial
Sign up to get notified when there's something new on the MEK162 vs Dacarbazine in NRAS+ Melanoma Clinical Trial page.

Latest updates to the MEK162 vs Dacarbazine in NRAS+ Melanoma Clinical Trial page
- Check4 days agoChange DetectedNew revision entry 'Revision: v3.6.5' is added to the study history, and the previous 'Revision: v3.6.4' entry is removed. This updates the history to reflect the latest version of the record in the log.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedA new revision entry v3.6.4 was added to the study record history, replacing the previous v3.6.3. This update reflects a change to the revision history itself rather than to study data.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check47 days agoChange DetectedRevision label updated from v3.6.0 to v3.6.3 in the page footer. This reflects a newer UI/system update to the record history page.SummaryDifference0.1%

- Check61 days agoChange DetectedRecruitment is now closed (no longer looking for participants) and the record has been updated to revision v3.6.0, replacing the previous revision v3.5.5.SummaryDifference0.3%

- Check68 days agoChange DetectedA new revision label 'Revision: v3.5.5' was added to the page history. The previous label 'Revision: v3.5.4' was removed.SummaryDifference0.1%

- Check90 days agoChange DetectedA new revision entry v3.5.4 has been added to the Study Record Versions, and the previous revision v3.5.3 has been removed from the history. This updates the revision history to reflect the latest submission.SummaryDifference0.1%

Stay in the know with updates to MEK162 vs Dacarbazine in NRAS+ Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MEK162 vs Dacarbazine in NRAS+ Melanoma Clinical Trial page.